Investor Relations

Stock Quote

About SWK Holdings

We are a specialized finance company with a specific focus on opportunities in the global healthcare sector. We provide innovative capital solutions to a broad range of life science companies, institutions and inventors.

We provide capital to our business partners through our own balance sheet as well as through our investment advisory clients, which include family offices and institutional investors. Our broad capital base positions us to be the partner of choice for life science entities looking for flexible, nontraditional sources of capital.

Our management team has extensive experience specifically in healthcare-related principal investing and structured finance, resulting in a deep understanding of business opportunities in the life science sector.

For our investors, we expect to provide superior risk-adjusted returns on capital by investing in marketed ethical product cash flow streams.

Latest News
Jan 12, 2021

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation...

Jan 07, 2021

Rajiv Khosla, Ph.D., named Chief Executive Officer Gary A. Shangold, M.D., appointed Chief Medical Officer Received two milestone payments totaling $5 million from Cara Therapeutics per licensing...

Jan 04, 2021

Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty...

View All Releases

Latest Presentation

Fall Investor Summit Webcast and Presentation
September 16, 2019

Listen to Webcast

Upcoming & Recent Events
Monday, November 16, 2020
10:00am - 11:00am EST

View all Events

Contact Us

Maureen McEnroe
Tiberend Strategic Advisors, Inc.
(212) 375-2664


To see news related to SWK Holdings' Portfolio, click here.

Latest Quarterly Results